PubHawk
J Am Soc Nephrol June 2021 PMID 33753537

Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial.

An S De Vriese, Rogier Caluwé, Hans Van Der Meersch, Koen De Boeck, Dirk De Bacquer

Download social card

Mentions

128
Peak: 99 in Mar 2021
across 4 sources since Mar 2021

Extended reach

338,166
potential audience

Total likes

379

Video views

8,846

Mentions per month

Mar 2021 – Feb 2024

Where it's discussed

  • X / Twitter121 posts
  • News3 articles
  • YouTube2 videos
  • Blogs2 articles

AI synopsis

What people are saying

The discussions highlight key findings from the research, such as one post noting a 59% reduction in primary cardiovascular events with rivaroxaban compared to vitamin K antagonists. Participants celebrate the study as providing crucial evidence for clinical practice, using phrases like 'just the paper we needed' and 'at last a hemodialysis RCT' to convey excitement and validation of the findings. The tone is largely positive, reflecting enthusiasm for improved patient care options.

AgreementStrong agreement

The majority of discussions reflect a strong endorsement of the study's findings, particularly the efficacy of rivaroxaban over vitamin K antagonists.

InterestHigh interest

Participants in the discussions express significant curiosity about the study, often referencing specific outcomes and comparisons drawn in the research.

EngagementModerate engagement

While most posts share the study, a few delve deeper into specific details, suggesting moderate levels of engagement with the content.

ImpactHigh impact

Many participants emphasize the importance of the study, indicating that they believe its findings will influence treatment choices for hemodialysis patients.

Abstract in brief

  • The study compared the safety and efficacy of vitamin K antagonists (VKAs) with rivaroxaban in hemodialysis patients suffering from atrial fibrillation over an 18-month period, with an extended follow-up.
  • Results showed that rivaroxaban significantly reduced the rate of primary cardiovascular events and symptomatic limb ischemia compared to VKAs, with lower rates of major bleeding as well.
  • However, there were no notable differences in overall death rates or risk of stroke between the treatment groups, highlighting the need for careful anticoagulant selection in this patient population.
Read the full abstract

Top posts

Most liked on X and Bluesky
Jonathan Chávez
@JonathanNefro · X

En HEMODIÁLISIS con fibrilación auricular (no valvular) RIBAROXABAN 10mg redujo 59% la probabilidad del evento compuesto cardiovascular, en comparación a antagonistas vitK (ej. Warfarina), con menos riesgo de sangrado. Ensayo clínico Valkyrie JASN 2021 https://t.co/LnLD2MVw0Y https://t.co/bKVjePkO8X

Mar 24, 2021 · 87 likes · 34 shares · 37,763 followers View post →
Bloodman
@Bloodman · X

At last a hemodialysis RCT - DOAC better that warfarin: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenteral RCT https://t.co/Sk5TbCZndc

Mar 22, 2021 · 83 likes · 39 shares · 6,398 followers View post →
Ivan Velázquez
@Nephro_Ivan · X

Justo el paper que faltaba para tener más certeza en el uso de RIVAROXAVAN en HD

Mar 24, 2021 · 42 likes · 14 shares · 2,464 followers View post →
Hector Madariaga, MD FASN
@HecmagsMD · X

Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial @JASN_News https://t.co/OJJl54Pxmi

Mar 24, 2021 · 37 likes · 13 shares · 4,954 followers View post →
Ugur Canpolat
@ugurcanpolatmd · X

VKA vs. #Rivaroxaban in #Hemodialysis Patients with #AtrialFibrillation. @ASNKidney @JASN_News @TKDsosyal @turkkardiyoloji https://t.co/OBmPz9wUR8

May 1, 2021 · 9 likes · 1 share · 2,319 followers View post →
Ivan Čurić Dr Zebra
@DrZebra1 · X

Važna studija.Rivaroxaban 10 mg efikasniji i bezbedniji od OAK u CKD V i AF Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial https://t.co/dTnAvd6h7Z

Feb 28, 2022 · 6 likes · 4,968 followers View post →

All mentions

Medicina Interna HCSBA
@MHcsba · X

RT @JonathanNefro: En HEMODIÁLISIS con fibrilación auricular (no valvular) RIBAROXABAN 10mg redujo 59% la probabilidad del evento compuesto…

May 21, 2022 · 34 shares · 8,856 followers View post →
Ivan Čurić Dr Zebra
@DrZebra1 · X

Važna studija.Rivaroxaban 10 mg efikasniji i bezbedniji od OAK u CKD V i AF Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial https://t.co/dTnAvd6h7Z

Feb 28, 2022 · 6 likes · 4,968 followers View post →
Med Peds Hospitalist
@medpedshosp · X

RT @rIvS_IvAn: Justo el paper que faltaba para tener más certeza en el uso de RIVAROXAVAN en HD

Nov 4, 2021 · 14 shares · 14,250 followers View post →
Omar M. Abdelfattah, MD, FESC
@AbdelfattahMD · X

@jdmcgee123 @mmc_im https://t.co/YQf5w2Z1zC

Aug 17, 2021 · 2 likes · 1,550 followers View post →
pinacol
@pinacol · X

RT @pinacol: 【RCT】心房細動のある透析患者へのビタミンK拮抗薬（VKA）、リバーロキサバン（Riv）およびリバーロキサバン+ビタミンK2の投与を比較した結果（Riv+K）、RivおよびRiv+KはVKAより致死的および非致死的心血管イベントを減少させた。 #ペ読…

Jun 15, 2021 · 1 share · 1,616 followers View post →
بدر الحربي
@BaderAlsobihi · X

RT @HecmagsMD: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multice…

Jun 15, 2021 · 13 shares · 1,871 followers View post →
CQI365
@vierylin · X

透析Af 病患使用NOAC與Wafarin 的比較 Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial | American Society of Nephrology https://t.co/eJIWZRPbgx

Jun 2, 2021 · 133 followers View post →
Vitor Sforni
@VitorSforni · X

I think it is the first trial of a DOAC vs AVK in ESRD. https://t.co/T5LsGKjIlK https://t.co/BRIulnevFo

Jun 1, 2021 · 93 followers View post →
Manu Morales Sánchez
@Manugrillo2 · X

RT @U_Cnplt: VKA vs. #Rivaroxaban in #Hemodialysis Patients with #AtrialFibrillation. @ASNKidney @JASN_News @TKDsosyal @turkkardiyoloji ht…

May 14, 2021 · 1 share · 2,140 followers View post →
Trip Primary Care
@TripPrimaryCare · X

New2Trip: Safety & Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients w/ Atrial Fibrillation: Multicenter Randomized Controlled Trial https://t.co/2AInGzL8sj

May 9, 2021 · 2,476 followers View post →
Trip Primary Care
@TripPrimaryCare · X

New2Trip: Safety & Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients w/ Atrial Fibrillation: Multicenter Randomized Controlled Trial https://t.co/2AInGzL8sj

May 7, 2021 · 2,476 followers View post →
Trip Primary Care
@TripPrimaryCare · X

New2Trip: Safety & Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients w/ Atrial Fibrillation: Multicenter Randomized Controlled Trial https://t.co/2AInGzL8sj

May 3, 2021 · 2,476 followers View post →
Ugur Canpolat
@ugurcanpolatmd · X

VKA vs. #Rivaroxaban in #Hemodialysis Patients with #AtrialFibrillation. @ASNKidney @JASN_News @TKDsosyal @turkkardiyoloji https://t.co/OBmPz9wUR8

May 1, 2021 · 9 likes · 1 share · 2,319 followers View post →
Paco Cañestro
@fcanestro · X

RT @TripPrimaryCare: New2Trip: Safety & Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients w/ Atrial Fibrillatio…

May 1, 2021 · 1 share · 2,182 followers View post →
Trip Primary Care
@TripPrimaryCare · X

New2Trip: Safety & Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients w/ Atrial Fibrillation: Multicenter Randomized Controlled Trial https://t.co/2AInGzL8sj

May 1, 2021 · 2 likes · 1 share · 2,476 followers View post →
Bongani Mayosi Health Sciences Library (BMHSL)
@uct_bmhsl · X

RT @tripdatabase: New2Trip: Safety & Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients w/ Atrial Fibrillation:…

Apr 30, 2021 · 1 share · 1,598 followers View post →
Trip Database
@tripdatabase · X

New2Trip: Safety & Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients w/ Atrial Fibrillation: Multicenter Randomized Controlled Trial https://t.co/U0vaRb08P6

Apr 30, 2021 · 1 share · 4,417 followers View post →
Trip Primary Care
@TripPrimaryCare · X

New2Trip: Safety & Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients w/ Atrial Fibrillation: Multicenter Randomized Controlled Trial https://t.co/2AInGzL8sj

Apr 25, 2021 · 2,476 followers View post →
Trip Database
@tripdatabase · X

New2Trip: Safety & Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients w/ Atrial Fibrillation: Multicenter Randomized Controlled Trial https://t.co/U0vaRb08P6

Apr 23, 2021 · 4,417 followers View post →
Trip Primary Care
@TripPrimaryCare · X

New2Trip: Safety & Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients w/ Atrial Fibrillation: Multicenter Randomized Controlled Trial https://t.co/2AInGzL8sj

Apr 23, 2021 · 2,476 followers View post →
Manu Morales Sánchez
@Manugrillo2 · X

@JonathanNefro @DrCarlosEGarcia Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial https://t.co/CSsNKHxH3W

Apr 14, 2021 · 2 likes · 2,140 followers View post →
Manu Morales Sánchez
@Manugrillo2 · X

Safety and Efficacy of Vitamin K Antagonists versus #Rivaroxaban in #Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial https://t.co/CSsNKHxH3W

Apr 14, 2021 · 2,140 followers View post →
Henry Giovanny Yancy Caballero
@GiovannyYancy · X

RT @rIvS_IvAn: Justo el paper que faltaba para tener más certeza en el uso de RIVAROXAVAN en HD

Mar 28, 2021 · 14 shares · 19 followers View post →
pinacol
@pinacol · X

【RCT】心房細動のある透析患者へのビタミンK拮抗薬（VKA）、リバーロキサバン（Riv）およびリバーロキサバン+ビタミンK2の投与を比較した結果（Riv+K）、RivおよびRiv+KはVKAより致死的および非致死的心血管イベントを減少させた。 #ペ読 https://t.co/R94rUAxXC0

Mar 26, 2021 · 3 likes · 1 share · 1,616 followers View post →
Gert Meeus
@gertmeeus_MD · X

RT @RogierCaluwe: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Mult…

Mar 26, 2021 · 2 shares · 584 followers View post →
Dra. Erica Yama
@Ericayamitayama · X

RT @JonathanNefro: En HEMODIÁLISIS con fibrilación auricular (no valvular) RIBAROXABAN 10mg redujo 59% la probabilidad del evento compuesto…

Mar 25, 2021 · 34 shares · 97 followers View post →
the paper link
@the_paper_link · X

RT @the_paper_link: Trend new: De Vriese AS, ..., De Bacquer D (J Am Soc Nephrol) __Safety and Efficacy of Vitamin K Antagonists versus Ri…

Mar 25, 2021 · 1 share · 137 followers View post →
Dra.Paolakarinagarcia
@DraPaolagarcia · X

RT @JonathanNefro: En HEMODIÁLISIS con fibrilación auricular (no valvular) RIBAROXABAN 10mg redujo 59% la probabilidad del evento compuesto…

Mar 25, 2021 · 34 shares · 212 followers View post →
Jared siñani
@JaredSinani · X

RT @JonathanNefro: En HEMODIÁLISIS con fibrilación auricular (no valvular) RIBAROXABAN 10mg redujo 59% la probabilidad del evento compuesto…

Mar 25, 2021 · 34 shares · 10 followers View post →
the paper link
@the_paper_link · X

Trend new: De Vriese AS, ..., De Bacquer D (J Am Soc Nephrol) __Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial__ https://t.co/zGvSVcCdEe

Mar 25, 2021 · 1 share · 137 followers View post →
Dra. Juguete
@LiviaRaga · X

RT @JonathanNefro: En HEMODIÁLISIS con fibrilación auricular (no valvular) RIBAROXABAN 10mg redujo 59% la probabilidad del evento compuesto…

Mar 25, 2021 · 34 shares · 218 followers View post →
Manuel Vazquez V
@ManuelVVidaurre · X

RT @JonathanNefro: En HEMODIÁLISIS con fibrilación auricular (no valvular) RIBAROXABAN 10mg redujo 59% la probabilidad del evento compuesto…

Mar 25, 2021 · 34 shares · 276 followers View post →
Lizbeth MR
@1209Lizbeth · X

RT @JonathanNefro: En HEMODIÁLISIS con fibrilación auricular (no valvular) RIBAROXABAN 10mg redujo 59% la probabilidad del evento compuesto…

Mar 25, 2021 · 34 shares · 42 followers View post →
Favio varon suarez
@faviomagno777 · X

RT @JonathanNefro: En HEMODIÁLISIS con fibrilación auricular (no valvular) RIBAROXABAN 10mg redujo 59% la probabilidad del evento compuesto…

Mar 25, 2021 · 34 shares · 87 followers View post →
Carlos Vélez
@Carlosvaavg · X

RT @JonathanNefro: En HEMODIÁLISIS con fibrilación auricular (no valvular) RIBAROXABAN 10mg redujo 59% la probabilidad del evento compuesto…

Mar 25, 2021 · 34 shares · 4 followers View post →
M.Carmen Duran
@NITOSLAV · X

RT @JonathanNefro: En HEMODIÁLISIS con fibrilación auricular (no valvular) RIBAROXABAN 10mg redujo 59% la probabilidad del evento compuesto…

Mar 25, 2021 · 34 shares · 197 followers View post →
ElenaGre
@ElenaGre3 · X

RT @HecmagsMD: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multice…

Mar 25, 2021 · 13 shares · 33 followers View post →
María Azancot
@maazancot · X

RT @HecmagsMD: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multice…

Mar 25, 2021 · 13 shares · 999 followers View post →
Bryan Quintanilla
@Brysten23 · X

RT @JonathanNefro: En HEMODIÁLISIS con fibrilación auricular (no valvular) RIBAROXABAN 10mg redujo 59% la probabilidad del evento compuesto…

Mar 25, 2021 · 34 shares · 275 followers View post →
Carlos
@MarvinHarris76 · X

RT @rIvS_IvAn: Justo el paper que faltaba para tener más certeza en el uso de RIVAROXAVAN en HD

Mar 25, 2021 · 14 shares · 4,513 followers View post →
Kevs
@Kevs_518 · X

RT @JonathanNefro: En HEMODIÁLISIS con fibrilación auricular (no valvular) RIBAROXABAN 10mg redujo 59% la probabilidad del evento compuesto…

Mar 25, 2021 · 34 shares · 16 followers View post →
Ester Sifuentes
@T_Tsita · X

RT @JonathanNefro: En HEMODIÁLISIS con fibrilación auricular (no valvular) RIBAROXABAN 10mg redujo 59% la probabilidad del evento compuesto…

Mar 24, 2021 · 34 shares · 153 followers View post →
Norma
@Norma06657442 · X

RT @JonathanNefro: En HEMODIÁLISIS con fibrilación auricular (no valvular) RIBAROXABAN 10mg redujo 59% la probabilidad del evento compuesto…

Mar 24, 2021 · 34 shares · 113 followers View post →
Dr. Ronald Caraballo NEFROLOGO
@ronald_nefro · X

RT @JonathanNefro: En HEMODIÁLISIS con fibrilación auricular (no valvular) RIBAROXABAN 10mg redujo 59% la probabilidad del evento compuesto…

Mar 24, 2021 · 34 shares · 662 followers View post →
Katy Rios
@r1_katy · X

RT @HecmagsMD: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multice…

Mar 24, 2021 · 13 shares · 651 followers View post →
Gerardo Zavala García
@ZavalaGerard · X

RT @rIvS_IvAn: Justo el paper que faltaba para tener más certeza en el uso de RIVAROXAVAN en HD

Mar 24, 2021 · 14 shares · 475 followers View post →
szulkifli
@sanusizulkifli · X

RT @HecmagsMD: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multice…

Mar 24, 2021 · 13 shares · 5,467 followers View post →
Pablo
@pabloruanos · X

RT @JonathanNefro: En HEMODIÁLISIS con fibrilación auricular (no valvular) RIBAROXABAN 10mg redujo 59% la probabilidad del evento compuesto…

Mar 24, 2021 · 34 shares · 1,123 followers View post →
Gabriela Sánchez E.
@gsestanga · X

RT @JonathanNefro: En HEMODIÁLISIS con fibrilación auricular (no valvular) RIBAROXABAN 10mg redujo 59% la probabilidad del evento compuesto…

Mar 24, 2021 · 34 shares · 1,482 followers View post →
♰
@drmistico17 · X

RT @JonathanNefro: En HEMODIÁLISIS con fibrilación auricular (no valvular) RIBAROXABAN 10mg redujo 59% la probabilidad del evento compuesto…

Mar 24, 2021 · 34 shares · 831 followers View post →
CQI365
@vierylin · X

Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial | American Society of Nephrology https://t.co/jAc3UN7BML

Mar 24, 2021 · 133 followers View post →
Lissfenidato
@Lissfenidato · X

RT @JonathanNefro: En HEMODIÁLISIS con fibrilación auricular (no valvular) RIBAROXABAN 10mg redujo 59% la probabilidad del evento compuesto…

Mar 24, 2021 · 34 shares · 1,447 followers View post →
Erick Chazaro
@erick_chazaro · X

RT @JonathanNefro: En HEMODIÁLISIS con fibrilación auricular (no valvular) RIBAROXABAN 10mg redujo 59% la probabilidad del evento compuesto…

Mar 24, 2021 · 34 shares · 115 followers View post →
Irving Trejo Curiel
@irvtc · X

RT @JonathanNefro: En HEMODIÁLISIS con fibrilación auricular (no valvular) RIBAROXABAN 10mg redujo 59% la probabilidad del evento compuesto…

Mar 24, 2021 · 34 shares · 32 followers View post →
fausto heredia z.
@drfherediaz · X

RT @JonathanNefro: En HEMODIÁLISIS con fibrilación auricular (no valvular) RIBAROXABAN 10mg redujo 59% la probabilidad del evento compuesto…

Mar 24, 2021 · 34 shares · 4,362 followers View post →
Lucsob
@sobcuer · X

RT @JonathanNefro: En HEMODIÁLISIS con fibrilación auricular (no valvular) RIBAROXABAN 10mg redujo 59% la probabilidad del evento compuesto…

Mar 24, 2021 · 34 shares · 260 followers View post →
✨
@DraPettite · X

RT @JonathanNefro: En HEMODIÁLISIS con fibrilación auricular (no valvular) RIBAROXABAN 10mg redujo 59% la probabilidad del evento compuesto…

Mar 24, 2021 · 34 shares · 1,404 followers View post →
Vicryl 3-0
@JAvazquezC · X

RT @JonathanNefro: En HEMODIÁLISIS con fibrilación auricular (no valvular) RIBAROXABAN 10mg redujo 59% la probabilidad del evento compuesto…

Mar 24, 2021 · 34 shares · 411 followers View post →
Francisco Valga, MD, PhD
@Fran__99_ · X

RT @JonathanNefro: En HEMODIÁLISIS con fibrilación auricular (no valvular) RIBAROXABAN 10mg redujo 59% la probabilidad del evento compuesto…

Mar 24, 2021 · 34 shares · 711 followers View post →
Dra. Migdalia Martínez
@nefroproteccion · X

RT @JonathanNefro: En HEMODIÁLISIS con fibrilación auricular (no valvular) RIBAROXABAN 10mg redujo 59% la probabilidad del evento compuesto…

Mar 24, 2021 · 34 shares · 16 followers View post →
Jonathan Chávez
@JonathanNefro · X

En HEMODIÁLISIS con fibrilación auricular (no valvular) RIBAROXABAN 10mg redujo 59% la probabilidad del evento compuesto cardiovascular, en comparación a antagonistas vitK (ej. Warfarina), con menos riesgo de sangrado. Ensayo clínico Valkyrie JASN 2021 https://t.co/LnLD2MVw0Y https://t.co/bKVjePkO8X

Mar 24, 2021 · 87 likes · 34 shares · 37,763 followers View post →
Jorge Chancay, MD
@jchancay2 · X

RT @HecmagsMD: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multice…

Mar 24, 2021 · 13 shares · 143 followers View post →
NJE
@NJE70997753 · X

RT @rIvS_IvAn: Justo el paper que faltaba para tener más certeza en el uso de RIVAROXAVAN en HD

Mar 24, 2021 · 14 shares · 30 followers View post →
Steve Morrissey
@SteveWMorrissey · X

RT @RogierCaluwe: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Mult…

Mar 24, 2021 · 2 shares · 30 followers View post →
David Arroyo
@dvdrry · X

RT @rIvS_IvAn: Justo el paper que faltaba para tener más certeza en el uso de RIVAROXAVAN en HD

Mar 24, 2021 · 14 shares · 2,987 followers View post →
Jose De La Flor
@josedelaflor4 · X

RT @HecmagsMD: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multice…

Mar 24, 2021 · 13 shares · 460 followers View post →
Anace Pastor ✨️ Renalis
@anace710 · X

RT @HecmagsMD: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multice…

Mar 24, 2021 · 13 shares · 1,899 followers View post →
David Arroyo
@dvdrry · X

RT @HecmagsMD: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multice…

Mar 24, 2021 · 13 shares · 2,987 followers View post →
Damian Silbermins
@nos3as · X

RT @Bloodman: At last a hemodialysis RCT - DOAC better that warfarin: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in…

Mar 24, 2021 · 39 shares · 170 followers View post →
Ricky Turgeon PharmD
@Ricky_Turgeon · X

RT @HecmagsMD: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multice…

Mar 24, 2021 · 13 shares · 1,594 followers View post →
Till Treutler
@TillTreutler · X

RT @HecmagsMD: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multice…

Mar 24, 2021 · 13 shares · 95 followers View post →
Matthew Sparks, MD
@Nephro_Sparks · X

RT @HecmagsMD: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multice…

Mar 24, 2021 · 13 shares · 21,182 followers View post →
Hector Madariaga, MD FASN
@HecmagsMD · X

Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial @JASN_News https://t.co/OJJl54Pxmi

Mar 24, 2021 · 37 likes · 13 shares · 4,954 followers View post →
Rogier Caluwé
@RogierCaluwe · X

Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial | American Society of Nephrology https://t.co/XOBfGoHaxu

Mar 24, 2021 · 6 likes · 2 shares · 83 followers View post →
Josué Ruiz
@JosueRuizmd · X

RT @rIvS_IvAn: Justo el paper que faltaba para tener más certeza en el uso de RIVAROXAVAN en HD

Mar 24, 2021 · 14 shares · 223 followers View post →
Jose De La Flor
@josedelaflor4 · X

RT @rIvS_IvAn: Justo el paper que faltaba para tener más certeza en el uso de RIVAROXAVAN en HD

Mar 24, 2021 · 14 shares · 460 followers View post →
javier tejeda
@jav_tejeda · X

RT @rIvS_IvAn: Justo el paper que faltaba para tener más certeza en el uso de RIVAROXAVAN en HD

Mar 24, 2021 · 14 shares · 515 followers View post →
Krishna Marcos Escobar
@k_mare24 · X

RT @rIvS_IvAn: Justo el paper que faltaba para tener más certeza en el uso de RIVAROXAVAN en HD

Mar 24, 2021 · 14 shares · 51 followers View post →
Current Nephrology
@CNephrology · X

RT @rIvS_IvAn: Justo el paper que faltaba para tener más certeza en el uso de RIVAROXAVAN en HD

Mar 24, 2021 · 14 shares · 1,322 followers View post →
Olga Gavin
@ogavin70 · X

RT @Bloodman: At last a hemodialysis RCT - DOAC better that warfarin: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in…

Mar 24, 2021 · 39 shares · 126 followers View post →
ad
@aDiigum · X

RT @rIvS_IvAn: Justo el paper que faltaba para tener más certeza en el uso de RIVAROXAVAN en HD

Mar 24, 2021 · 14 shares · 9 followers View post →
Ivan Velázquez
@Nephro_Ivan · X

Justo el paper que faltaba para tener más certeza en el uso de RIVAROXAVAN en HD

Mar 24, 2021 · 42 likes · 14 shares · 2,464 followers View post →
American Society of Pediatric Nephrology
@ASPNeph · X

Safety and Efficacy of Vitamin K Antagonists versus #Rivaroxaban in Hemodialysis Patients with #AtrialFibrillation: A Multicenter Randomized Controlled Trial #RCT #HD @JASN_News https://t.co/EP1csMrEXL

Mar 24, 2021 · 5 likes · 10,150 followers View post →
Grupo CLAHT
@grupoclaht · X

RT @Bloodman: At last a hemodialysis RCT - DOAC better that warfarin: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in…

Mar 23, 2021 · 39 shares · 856 followers View post →
peoliver
@pavel_olivera · X

RT @Bloodman: At last a hemodialysis RCT - DOAC better that warfarin: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in…

Mar 23, 2021 · 39 shares · 242 followers View post →
Clare Morlidge
@claremorlidge · X

RT @Bloodman: At last a hemodialysis RCT - DOAC better that warfarin: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in…

Mar 23, 2021 · 39 shares · 345 followers View post →
renalRCTs
@renalRCTs · X

Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial https://t.co/RV4UXW7HhP https://t.co/QkqiqsNEY1

Mar 23, 2021 · 1 like · 39 followers View post →
Parham Sadeghipour
@psadeghipour · X

RT @Bloodman: At last a hemodialysis RCT - DOAC better that warfarin: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in…

Mar 23, 2021 · 39 shares · 364 followers View post →
Flexamethasone
@flexamethasone · X

RT @Bloodman: At last a hemodialysis RCT - DOAC better that warfarin: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in…

Mar 23, 2021 · 39 shares · 48 followers View post →
Rami Kafa
@RamiKafa · X

RT @Bloodman: At last a hemodialysis RCT - DOAC better that warfarin: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in…

Mar 23, 2021 · 39 shares · 1,181 followers View post →
Zainab Al Duhailib
@ZDuhailib · X

RT @Bloodman: At last a hemodialysis RCT - DOAC better that warfarin: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in…

Mar 23, 2021 · 39 shares · 418 followers View post →
Natasha Wiles
@NATASHALYKOP · X

RT @Bloodman: At last a hemodialysis RCT - DOAC better that warfarin: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in…

Mar 23, 2021 · 39 shares · 147 followers View post →
Mahmoud Numan
@M_Jafar · X

RT @Bloodman: At last a hemodialysis RCT - DOAC better that warfarin: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in…

Mar 23, 2021 · 39 shares · 14 followers View post →
THS
@Ryan725 · X

RT @Bloodman: At last a hemodialysis RCT - DOAC better that warfarin: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in…

Mar 23, 2021 · 39 shares · 522 followers View post →
Mojaat Malek https://www.researchgate.net/profile/
@MojaatM · X

Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial https://t.co/19Jn81oZXP

Mar 23, 2021 · 509 followers View post →
مرتضى السلمان
@MortadaMortadah · X

RT @Bloodman: At last a hemodialysis RCT - DOAC better that warfarin: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in…

Mar 23, 2021 · 39 shares · 1,603 followers View post →
Manu Morales Sánchez
@Manugrillo2 · X

RT @Bloodman: At last a hemodialysis RCT - DOAC better that warfarin: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in…

Mar 23, 2021 · 39 shares · 2,140 followers View post →
Gabriela Cesarman
@GabrielaCesarm4 · X

RT @Bloodman: At last a hemodialysis RCT - DOAC better that warfarin: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in…

Mar 23, 2021 · 39 shares · 35 followers View post →
Yvelynne Kelly
@YvelynneKelly · X

RT @Bloodman: At last a hemodialysis RCT - DOAC better that warfarin: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in…

Mar 23, 2021 · 39 shares · 710 followers View post →
Pierre Vx
@PierreNMV7 · X

RT @Bloodman: At last a hemodialysis RCT - DOAC better that warfarin: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in…

Mar 23, 2021 · 39 shares · 25 followers View post →
Manu Morales Sánchez
@Manumoraless · X

RT @Bloodman: At last a hemodialysis RCT - DOAC better that warfarin: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in…

Mar 23, 2021 · 39 shares · 468 followers View post →
Ragada El-Damanawi
@ElRagada · X

RT @Bloodman: At last a hemodialysis RCT - DOAC better that warfarin: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in…

Mar 23, 2021 · 39 shares · 834 followers View post →
Santhosh Ambika
@RenoHemonc · X

RT @Bloodman: At last a hemodialysis RCT - DOAC better that warfarin: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in…

Mar 23, 2021 · 39 shares · 4,062 followers View post →
Abdelhamid Hamdy
@abdelhamed012 · X

RT @Bloodman: At last a hemodialysis RCT - DOAC better that warfarin: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in…

Mar 23, 2021 · 39 shares · 3,422 followers View post →
Ajar Kochar
@Ajar_Kochar · X

RT @Bloodman: At last a hemodialysis RCT - DOAC better that warfarin: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in…

Mar 23, 2021 · 39 shares · 3,204 followers View post →
Sandy Wong
@SandyWong02111 · X

RT @Bloodman: At last a hemodialysis RCT - DOAC better that warfarin: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in…

Mar 22, 2021 · 39 shares · 1,469 followers View post →
MD. Msc. Ricardo Fabián Mosquera C.
@drrfmc · X

RT @Bloodman: At last a hemodialysis RCT - DOAC better that warfarin: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in…

Mar 22, 2021 · 39 shares · 693 followers View post →
Amy Yau
@amyaimei · X

RT @Bloodman: At last a hemodialysis RCT - DOAC better that warfarin: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in…

Mar 22, 2021 · 39 shares · 2,277 followers View post →
Joshua Levenson, MD
@jelevenson · X

RT @Bloodman: At last a hemodialysis RCT - DOAC better that warfarin: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in…

Mar 22, 2021 · 39 shares · 4,093 followers View post →
Kartik
@kartikeya4 · X

RT @Bloodman: At last a hemodialysis RCT - DOAC better that warfarin: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in…

Mar 22, 2021 · 39 shares · 352 followers View post →
Erin Espinoza, DO
@DrErin_DO · X

RT @Bloodman: At last a hemodialysis RCT - DOAC better that warfarin: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in…

Mar 22, 2021 · 39 shares · 219 followers View post →
Craig Hofmeister
@EagleMyeloma · X

RT @Bloodman: At last a hemodialysis RCT - DOAC better that warfarin: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in…

Mar 22, 2021 · 39 shares · 3,344 followers View post →
santosh dhungana
@saniom1 · X

RT @Bloodman: At last a hemodialysis RCT - DOAC better that warfarin: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in…

Mar 22, 2021 · 39 shares · 190 followers View post →
Guillaume Roberge
@GuillaumeRobMD · X

RT @Bloodman: At last a hemodialysis RCT - DOAC better that warfarin: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in…

Mar 22, 2021 · 39 shares · 138 followers View post →
Dr Jean Pierre Laroche #vacciné 6.0
@Echoraljpangio · X

RT @Bloodman: At last a hemodialysis RCT - DOAC better that warfarin: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in…

Mar 22, 2021 · 39 shares · 2,718 followers View post →
Hany Ragy
@Hragy · X

RT @Bloodman: At last a hemodialysis RCT - DOAC better that warfarin: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in…

Mar 22, 2021 · 39 shares · 80,552 followers View post →
Ahmad Masri
@MasriAhmadMD · X

RT @Bloodman: At last a hemodialysis RCT - DOAC better that warfarin: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in…

Mar 22, 2021 · 39 shares · 8,985 followers View post →
Denise Bittencourt
@Denise11252734 · X

RT @Bloodman: At last a hemodialysis RCT - DOAC better that warfarin: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in…

Mar 22, 2021 · 39 shares · 525 followers View post →
H.E. Hinson, MD MCR FAAN FNCS
@HollyEHinson · X

RT @Bloodman: At last a hemodialysis RCT - DOAC better that warfarin: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in…

Mar 22, 2021 · 39 shares · 1,869 followers View post →
Siavash Piran
@SiavashPiran · X

RT @Bloodman: At last a hemodialysis RCT - DOAC better that warfarin: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in…

Mar 22, 2021 · 39 shares · 146 followers View post →
Bloodman
@Bloodman · X

At last a hemodialysis RCT - DOAC better that warfarin: Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenteral RCT https://t.co/Sk5TbCZndc

Mar 22, 2021 · 83 likes · 39 shares · 6,398 followers View post →